Financial News

Financial Report: PAREXEL

Achieves record new business wins in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

Financial Report: PAREXEL
 
4Q Revenues: $538.6 million (+3%)  

4Q Earnings: $44.3 million (+30%)
 
FY Revenues: $2.1 billion (+4%)

FY Earnings: $156.5 million (+6%)

Comments: Backlog as of June 30, 2016 was $5.7 billion, an increase of approximately $400 million year over year. Backlog included gross new business wins in the quarter of $967 million, cancellations of $322 million, and a negative impact from foreign currency exchange rates of $37 million. The net book-to-bill ratio was 1.20 in the quarter.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters